These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1360888)

  • 1. Allele loss on chromosome 11p is associated with poor survival in ovarian cancer.
    Eccles DM; Gruber L; Stewart M; Steel CM; Leonard RC
    Dis Markers; 1992; 10(2):95-9. PubMed ID: 1360888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
    Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
    Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
    Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
    Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele loss from chromosome 17 in ovarian cancer.
    Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
    Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
    Purdie CA; Piris J; Bird CC; Wyllie AH
    J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
    Knowles MA; Shaw ME; Proctor AJ
    Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
    Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
    Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
    Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
    Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis.
    Watson RH; Neville PJ; Roy WJ; Hitchcock A; Campbell IG
    Oncogene; 1998 Jul; 17(2):207-12. PubMed ID: 9674705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.
    Vandamme B; Lissens W; Amfo K; De Sutter P; Bourgain C; Vamos E; De Grève J
    Cancer Res; 1992 Dec; 52(23):6646-52. PubMed ID: 1423308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of genes on the short arm of chromosome 11 in human lung carcinomas.
    Shiraishi M; Morinaga S; Noguchi M; Shimosato Y; Sekiya T
    Jpn J Cancer Res; 1987 Dec; 78(12):1302-8. PubMed ID: 2892820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.